Compounds > dabigatran
Page last updated: 2024-09-05

dabigatran and acenocoumarol

dabigatran has been researched along with acenocoumarol in 19 studies

Compound Research Comparison

Studies
(dabigatran)		Trials
(dabigatran)		Recent Studies (post-2010)
(dabigatran)		Studies
(acenocoumarol)		Trials
(acenocoumarol)		Recent Studies (post-2010) (acenocoumarol)
3,8872613,4901,390159328

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (5.26)29.6817
2010's16 (84.21)24.3611
2020's2 (10.53)2.80

Authors

AuthorsStudies
Ferrandis, R; Llau, JV; López Forte, C; Sapena, ML1
Calvo Romero, JM1
Valle Bernad, R1
Blanco-Molina, A1
Camarero, MO; Castaño, MP; Milla, SL; Piñero-Saavedra, M1
Barrios, V; Escobar, C1
Amato, A; Dentali, F; Dumonceau, JM; Paggi, S; Radaelli, F; Repici, A; Rondonotti, E1
Angelopoulou, SM; Bouziana, SD; Giampatzis, V; Hatzitolios, AI; Konstantara, F; Kostaki, S; Papadopoulou, M; Savopoulos, C; Spanou, M; Tziomalos, K1
Beney, J; Bochatay, L; Jordan-von Gunten, V; Petignat, PA; Roulet, L1
Bertrand, M; Blotière, PO; Bouillon, K; Maura, G; Ricordeau, P; Zureik, M1
Bartels, GL; Geluk, CA; Korenstra, J; Piersma-Wichers, M; Posma, JL; Rienstra, M; Tieleman, RG; Van Gelder, IC; Veeger, NJ; Wijtvliet, EP1
Nielsen, PB1
Asvestas, D; Bazoukis, G; Efremidis, M; Efremidis, T; Georgopoulos, S; Karamichalakis, N; Kolokathis, AM; Letsas, KP; Rokiza, A; Sakellaropoulou, A; Saplaouras, A; Sideris, A; Vlachos, K1
Cao, Q; Jacobs, MS; Jansman, FGA; Postma, MJ; Tieleman, RG; van Hulst, M; van Leent, MWJ1
Balsam, P; Bednarski, J; Filipiak, KJ; Grabowski, M; Kowalczuk, A; Kołtowski, Ł; Lodziński, P; Maciejewski, K; Opolski, G; Ozierański, K; Peller, M; Praska-Ogińska, A; Szepietowska, K; Tymińska, A; Zaboyska, I; Zaleska, M; Żukowska, K1
Bai, Y; Carmo, J; Esteve-Pastor, MA; Lip, GYH; Marín, F; Orenes-Piñero, E; Proietti, M; Rivera-Caravaca, JM; Roldán, V; Romanazzi, I; Romiti, GF1
Arcadi, FA; Calabrò, RS; Casella, C; Genovese, C; Giorgianni, R; Marino, S; Naro, A; Portaro, S1
García-Sempere, A; Hurtado, I; Peiró, S; Rodríguez-Bernal, CL; Sanfélix-Gimeno, G; Santa-Ana-Téllez, Y1
Agudo-Fernández, S; Calvo Morillas, I; Castaño Milla, C; González Blanco, A; Olmos Jerez, JA; Sancho Del Val, L1

Reviews

2 review(s) available for dabigatran and acenocoumarol

ArticleYear
[Anaesthesia and thromboembolic disease].
    Medicina clinica, 2008, Volume: 131 Suppl 2

    Topics: Acenocoumarol; Administration, Oral; Anesthesia, Conduction; Anticoagulants; Benzimidazoles; Clinical Protocols; Dabigatran; Early Ambulation; Fibrinolytic Agents; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Polysaccharides; Postoperative Complications; Pyridines; Risk Factors; Rivaroxaban; Safety; Surgical Procedures, Operative; Thiophenes; Venous Thromboembolism; Venous Thrombosis

2008
Management of anticoagulation in patients with acute gastrointestinal bleeding.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2015, Volume: 47, Issue:8

    Topics: Acenocoumarol; Acute Disease; Algorithms; Anticoagulants; Coagulants; Dabigatran; Endoscopy, Gastrointestinal; Gastrointestinal Hemorrhage; Humans; Rivaroxaban; Vitamin K; Warfarin

2015

Trials

1 trial(s) available for dabigatran and acenocoumarol

ArticleYear
Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT study.
    Kardiologia polska, 2018, Volume: 76, Issue:5

    Topics: Acenocoumarol; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Rivaroxaban; Thromboembolism; Warfarin

2018

Other Studies

16 other study(ies) available for dabigatran and acenocoumarol

ArticleYear
[Should dabigatran or vitamin K antagonists be used in prevention of stroke in patients with atrial fibrillation?].
    Revista clinica espanola, 2011, Volume: 211, Issue:3

    Topics: Acenocoumarol; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Risk Assessment; Stroke; Vitamin K

2011
[Introduction].
    Revista clinica espanola, 2012, Volume: 212 Suppl 1

    Topics: Acenocoumarol; Anticoagulants; Benzamides; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thromboembolism; Thrombosis; Warfarin

2012
[New advances in anticoagulation: is it time to forget about heparin and vitamin K antagonists? Yes].
    Revista clinica espanola, 2012, Volume: 212 Suppl 1

    Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Venous Thromboembolism; Warfarin

2012
DRESS syndrome induced by acenocoumarol with tolerance to warfarin and dabigatran: a case report.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:5

    Topics: Acenocoumarol; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Eruptions; Eosinophilia; Exanthema; Humans; Male; Venous Thromboembolism; Warfarin

2013
Can dabigatran improve blood pressure control?
    Future cardiology, 2013, Volume: 9, Issue:3

    Topics: Acenocoumarol; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Humans; Hypertension; Losartan; Male

2013
Acenocoumarol vs. low-dose dabigatran in real-world patients discharged after ischemic stroke.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2016, Volume: 27, Issue:2

    Topics: Acenocoumarol; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Brain Ischemia; Dabigatran; Drug Administration Schedule; Female; Humans; Male; Myocardial Infarction; Patient Discharge; Prospective Studies; Stroke; Survival Analysis; Thrombosis

2016
[Appropriateness of the prescriptions of conventional versus new oral anticoagulants at discharge from a department of internal medicine].
    La Revue de medecine interne, 2016, Volume: 37, Issue:9

    Topics: Acenocoumarol; Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Dabigatran; Drug Prescriptions; Female; Humans; Internal Medicine; Male; Middle Aged; Patient Discharge; Phenprocoumon; Retrospective Studies; Rivaroxaban; Vitamin K

2016
Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.
    The Lancet. Haematology, 2015, Volume: 2, Issue:4

    Topics: Acenocoumarol; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Male; Phenindione; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Thromboembolism; Vitamin K; Warfarin

2015
Effectiveness and safety of dabigatran versus acenocoumarol in 'real-world' patients with atrial fibrillation.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2016, Volume: 18, Issue:9

    Topics: Acenocoumarol; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Blood Coagulation; Chi-Square Distribution; Dabigatran; Disease-Free Survival; Drug Monitoring; Electronic Health Records; Female; Hemorrhage; Humans; Incidence; International Normalized Ratio; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Netherlands; Patient Safety; Propensity Score; Proportional Hazards Models; Retrospective Studies; Risk Factors; Stroke; Time Factors; Treatment Outcome

2016
Pharmacoepidemiological comparisons between acenocoumarol and dabigatran: interpretation of data reflecting clinical practice.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2016, Volume: 18, Issue:9

    Topics: Acenocoumarol; Anticoagulants; Antithrombins; Dabigatran; Humans

2016
Safety and efficacy of DOACs vs acenocoumarol in patients undergoing catheter ablation of atrial fibrillation.
    Clinical cardiology, 2017, Volume: 40, Issue:10

    Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Catheter Ablation; Dabigatran; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Pyrazoles; Pyridones; Registries; Risk Factors; Rivaroxaban; Thromboembolism; Time Factors; Treatment Outcome

2017
Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands.
    Journal of medical economics, 2017, Volume: 20, Issue:12

    Topics: Acenocoumarol; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cardiology; Dabigatran; Embolism; Female; Hemorrhage; Hospital Charges; Humans; Male; Middle Aged; Netherlands; Propensity Score; Retrospective Studies; Sex Factors; Stroke

2017
Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation.
    The American journal of cardiology, 2018, 09-01, Volume: 122, Issue:5

    Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Pyrazoles; Pyridones; Rivaroxaban; Spain; Stroke

2018
New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report.
    Medicina (Kaunas, Lithuania), 2019, Mar-17, Volume: 55, Issue:3

    Topics: Abortion, Spontaneous; Acenocoumarol; Adult; Antiphospholipid Syndrome; Antithrombins; Carotid Arteries; Computed Tomography Angiography; Dabigatran; Female; Follow-Up Studies; Humans; Product Surveillance, Postmarketing; Pulmonary Embolism; Stroke; Treatment Outcome; Venous Thrombosis; Warfarin

2019
Clinical outcomes of nonvitamin K oral anticoagulants and acenocoumarol for stroke prevention in contemporary practice: A population-based propensity-weighted cohort study.
    British journal of clinical pharmacology, 2021, Volume: 87, Issue:2

    Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cohort Studies; Dabigatran; Humans; India; Netherlands; Retrospective Studies; Rivaroxaban; Spain; Stroke

2021
RHEDAR study: Determination of the risk of gastrointestinal hemorrhage in treatment with dabigatran, acenocoumarol and rivaroxaban.
    Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:10

    Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Retrospective Studies; Rivaroxaban; Warfarin

2021